awmsg logo



methoxy polyethylene glycol-epoetin beta (Mircera®)


Reference No. 200

Publication date:
06/11/2009


Appraisal information

methoxy polyethylene glycol-epoetin beta (Mircera®) solution for injection


Company: Roche Products Ltd
BNF category: Nutrition and blood
NMG meeting date: 16/09/2009
AWMSG meeting date: 14/10/2009
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 1809
Ministerial ratification: 03/11/2009

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Methoxy polyethylene glycol-epoetin beta (Mircera®) is recommended as an option for use within NHS Wales for the treatment of adults with symptomatic anaemia associated with chronic kidney disease. AWMSG is of the opinion that methoxy polyethylene glycol-epoetin beta (Mircera®) is suitable for shared care within NHS Wales.
Final Appraisal Recommendation (FAR)
Download